
2.77 Delayed Data As of Sep 29 | ![]() Today’s Change | 1.72 Today|||52-Week Range 5.05 | -7.85% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 12.00, with a high estimate of 12.00 and a low estimate of 12.00. The median estimate represents a +333.21% increase from the last price of 2.77.
The current consensus among 1 polled investment analysts is to Buy stock in Acasti Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.